Fig. 2From: Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysisForest-plots of the outcome of MSC vs control patients. a Dichotomous analysis for the overall survival of patients infused with MSC vs control patients at last follow-up. b Risk to suffer grade IV aGvHD for patients from the MSC group compared with control patients. Dots and black lines represent the effect and 95% CI of individual studies. Black diamonds represent the overall effect size. Weights are from random-effects analysisBack to article page